Health Economics &
Outcomes Research

Overview

Health technology assessment (HTA) agencies and payers worldwide increasingly demand evidence of economic value for approval and market access of novel drugs, devices, and diagnostics. Avalon researchers and consultants have extensive knowledge and experience in the field of health economics and outcomes research (HEOR). These services include a wide variety of offerings across the product development continuum in pharmaceuticals, biotechnology, devices, and diagnostics. In the early stages of development, we provide insights and analysis on potential market size and the design of rigorous economic evaluations, such as clinical studies and cost-effectiveness analysis. In later stages of development, we can offer more in-depth analyses to support expanded market access. We are uniquely skilled in what we call “HEOR Analytics,” which includes novel statistical analyses of HEOR data, such as trial data or quality of life data, and novel applications of those analyses to statistical and economic models.